Hormonal Control of Haemostasis During Hypoglycaemia in Diabetes Mellitus

Summary

Factor VIII (FVIII) and plasminogen activator activity (PAA) rise during hypoglycaemia, and this might contribute to the vascular complications of diabetes. Similar changes in haemostasis accompany raised plasma levels of vasopressin (aVP) and adrenaline. To investigate the effects of these hormones on haemostasis during hypoglycaemia and the role of plasma insulin concentrations, eight insulin-dependent diabetic patients underwent controlled hypoglycaemia for 20 min and 13 diabetic patients were investigated during hyperinsulinaemia with blood glucose maintained at 8.0 mmol/1. During hypoglycaemia, insulin levels increased to median values of 114 mU/1, aVP rose from 0.5 to 4.4 (p <0.005) pg/ml and adrenaline from 0.4 to 4.4 nmol/l (p <0.005). FVIII coagulant activity (FVIII :C) rose from 0.75 to 1.09 iU/ml (p <0.01) and the ristocetin co-factor (FVIIIR:Co) and von Willebrand factor antigen (vWF:Ag) showed similar responses. PAA increased from 156 to 745 units (p <0.005). During hyperinsulinaemia, insulin rose following infusion from 24 to 52 and 118 mU/l, maintained for an hour at each level. Despite this, plasma aVP, FVIII :C, FVIIIR:Co, vWF:Ag and PAA remained unchanged. This study indicates that the marked changes in FVIII, vWF and PAA concentrations which accompany hypoglycaemia depend on low blood glucose and not raised plasma insulin. The response in probably mediated by increases in adrenaline and aVP, which are part of the physiological response to hypoglycaemia.

Keywords

Hypoglycaemia - Insulin - Vasopressin - Adrenaline - Factor VIII - Plasminogen activator - Insulin-dependent diabetes

• References

• 1 Bern MM, Cassani NP, Horton J, Rand L, Davis G. Changes in fibrinolysis and factor VIII coagulant antigen and ristocetin co-factor in diabetes mellitus and arteriosclerosis. Thromb Res 1980; 19: 831-839
• 2 Dornan TL, Rhymes IL, Cederholm-Williams SA, Rizza CR, Pepys MB, Bron AJ, Turner RC. Plasma haemostatic factors and diabetic retinopathy. Eur J Clin Invest 1983; 13: 231-235
• 3 Almer LO, Sundkvist G, Lilja B. Fibrinolytic activity, autonomic neuropathy and circulation in diabetes mellitus. Diabetes 1983; 32 (Suppl. 02) 4-7
• 4 Fuller H. Haemostatic function tests associated with diabetic retinopathy. Horm Metab Res 1981; II: 59-62
• 5 Juhan-Vague I, Vague P, Poisson C, Aillaud MF, Mendez C, Collen D. Effect of 24 hours of normoglycaemia on tissue-type plasminogen activator plasma levels in insulin-dependent diabetes. Thromb Haemostas 1984; 51: 97-98
• 6 Hughes A, McVerry BA, Wilkinson L, Goldstone AH, Lewis D, Bloom A. Diabetes, a hyper-coagulable state? Haemostatic variables in newly diagnosed type 2 diabetic patients. Acta Haem 1983; 69: 254-259
• 7 Gorral R JM, Webber RG, Frier BM. Increase in coagulation factor VIII activity in man following acute hypoglycaemia: Mediation via an adrenergic mechanism. Br J Haem 1980; 22: 301-305
• 8 Baylis PH, Zerbe RL, Robertson GL. Arginine vasopressin response to insulin-induced hypoglycaemia in man. J Clin End Metabol 1981; 53 (05) 935-940
• 9 Grant PJ, Davies JA, Tate GM, Boothby M, Prentice C RM. Effects of physiological concentrations of vasopressin on haemostatic function in man. Clin Sci 1985; 69: 471-476
• 10 Nussey SS, Bevan DH, Ang V TY, Jenkins JS. Effects of arginine vasopressin (AVP) infusions on circulatory concentrations of platelet AVP, factor VIII:C and von Willebrand factor. Thromb Haemostas 1986; 55: 34-36
• 11 Ingram G IC, Vaughan-Jones R. The rise in clotting factor VIII induced in man by adrenaline: effect of α and (β-blockers. J Phys 1966; 187: 447-454
• 12 Hardisty RM, MacPhearson JC. A one-stage factor VIII AHG assay and its use on venous and capillary plasma. Thromb Diathes Heamorrh 1962; 7: 215-229
• 13 Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966; 15: 45-52
• 14 Zuzel M, Nilsson IM, Aberg M. A method for measuring plasma ristocetin co-factor activity. Thromb Res 1978; 12 (05) 745-754
• 15 Nilsson IM, Hedner O, Pandolfi M. The measurement of fibrinolytic activities. Fibrinolytes and antifibrinolytes. (Ed) Mark Wardt F; Springer-Verlag, Berlin: 1978. S 107-134
• 16 Marsh NA. Measurement of fibrinolytic capacity by the euglobulin lysis time - a problem of units. Thromb Res 1977; 12: 197-200
• 17 Thomas TH, Lee MR. The specificity of antisera for the radioimmunoassay of arginine vasopressin in human plasma and urine during water loading. Clin Sci Mol Med 1976; 51: 525-536
• 18 Da Prada M, Zurcher G. Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine. Life Sci 1978; 19: 1161-1174
• 19 Grant PJ, Tate GM, Williams NS, Davies JA, Prentice C RM. Intra-operative activation of coagulation - a stimulus to thrombosis mediated by vasopressin?. Thromb Haemostas 1986; 55: 104-107
• 20 Grant PJ, Hughes JR, Dean JG, Davies JA, Prentice C RM. Vasopressin and catecholamine secretion during apomorphine induced nausea mediate acute changes in haemostatic function in man. Clin Sci 1986; 71: 621-624
• 21 Stout RW, Vallance-Owen J. Insulin and atheroma. Lancet 1979; 1: 1078-1080
• 22 Grant PJ, Davies JA, Tate GM, Boothby M, Prentice C RM. Does hypernatraemia promote thrombosis?. Thromb Res 1985; 40: 393-399